Fuller H B Co (FUL) · Oct 19, 2026 · Other events
Market check launched — Select asset review with proceeds intended for deleveraging
H.B. Fuller rejects Ancora’s richer acquisition proposal for its BAS business but launches a market check for less strategic assets to reduce debt.
H.B. Fuller is executing its Quantum Leap improvement program while carrying substantial leverage and preparing for another acquisition; after its third quarter, net debt was $1.96 billion and leverage was 3.0x adjusted EBITDA. The company rejects the higher BAS bid, but the strategic debate is no longer being dismissed. Ancora’s proposal rose from $1.1–$1.2 billion in August to $1.2–$1.4 billion in late September, so the direction of the pressure was already known; the new information is Fuller’s decision to respond with a formal, selective portfolio review rather than sell BAS outright. The board says the offer still does not reflect BAS’s value and remains too conditional. 〔0〕
| Item | Filing detail |
|---|---|
| Ancora cash proposal for BAS | $1.2–$1.4 billion (press release) |
| H.B. Fuller 2025 revenue | $3.5 billion (company overview) |
| Intended use of potential proceeds | Deleveraging (market-check announcement) |
The meaningful concession is a market check of less strategic assets. Fuller will test whether selected market segments and product lines can be separated and sold, with proceeds intended to reduce debt. 〔1〕 That gives the board a way to address activist demands and its leverage problem without giving up BAS, which management views as strategically important to the broader adhesives platform. 〔2〕
The immediate business effect is optionality, not cash or a completed restructuring. No buyer, price, transaction agreement, or proceeds are disclosed, and Fuller explicitly flags possible stranded costs, taxes, dis-synergies, and execution risks around Quantum Leap. The market check therefore advances the portfolio-optimization story, but it does not yet improve the balance sheet or prove that a sale can be completed on attractive terms.
Bottom line: Fuller holds the line on selling BAS, while opening the door to smaller asset sales that could reduce debt. It is a substantive shift toward portfolio action, but the financial benefit remains unproven until a buyer and transaction emerge.
Market check and potential asset-sale announcements
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!